Show simple item record

dc.contributor.authorMunir, T
dc.contributor.authorCohen, D
dc.contributor.authorPocock, C
dc.contributor.authorRawstron, A
dc.contributor.authorCollet, L
dc.contributor.authorMcParland, L
dc.contributor.authorChalmers, A
dc.contributor.authorVarghese, A
dc.contributor.authorSwift, S
dc.contributor.authorMilligan, D
dc.contributor.authorSchuh, A
dc.contributor.authorHamblin, M
dc.contributor.authorBloor, Adrian
dc.contributor.authorPettitt, A
dc.contributor.authorFegan, C
dc.contributor.authorBlundell, J
dc.contributor.authorAllsup, D
dc.contributor.authorGribben, J
dc.contributor.authorDuncombe, A
dc.contributor.authorMarshall, S
dc.contributor.authorGregory, W
dc.contributor.authorHillmen, P
dc.date.accessioned2016-04-01T10:06:53Zen
dc.date.available2016-04-01T10:06:53Zen
dc.date.issued2015en
dc.identifier.citationPhysical examination and MRD assessment rather than CT-scans is effective to assess responses in patients treated with fludarabine-based chemoimmunotherapy. Analysis of patients in the UK NCRI ADMIRE and ARCTIC trials. 2015, 56:26-27 Leuk Lymphomaen
dc.identifier.urihttp://hdl.handle.net/10541/604180en
dc.language.isoenen
dc.titlePhysical examination and MRD assessment rather than CT-scans is effective to assess responses in patients treated with fludarabine-based chemoimmunotherapy. Analysis of patients in the UK NCRI ADMIRE and ARCTIC trials.en
dc.typeArticleen
dc.contributor.departmentHaematology, St James' Institute of Oncology, Leedsen
dc.identifier.journalLeukemia & Lymphomaen


This item appears in the following Collection(s)

Show simple item record